Tepe; Jetze J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Tepe; Jetze J..The latest application filed is for "treatment of malignancies".

Company Profile

4.15.19

Tepe; Jetze J. - East Lansing MI

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Substituted phenothiazines as proteasome activators Grant 11,358,942 - Tepe , et al. June 14, 2	2022-06-14
Treatment Of Malignancies App 20220087979 - YUZBASIYAN-GURKAN; Vilma ; et al.	2022-03-24
Quinoline-based Proteasome Inhibitors And Uses Thereof App 20220048861 - Odom; Aaron ; et al.	2022-02-17
Quinoline-based Proteasome Inhibitors And Uses Thereof App 20200347019 - Odom; Aaron ; et al.	2020-11-05
Quinoline-based proteasome inhibitors and uses thereof Grant 10,752,590 - Odom , et al. A	2020-08-25
Small Molecule Proteasome Activators And Uses Thereof App 20200165216 - Tepe; Jetze J. ; et al.	2020-05-28
Treatment Of Malignancies App 20190030002 - Yuzbasiyan-Gurkan; Vilma ; et al.	2019-01-31
Quinoline-based Proteasome Inhibitors And Uses Thereof App 20180282280 - Odom; Aaron ; et al.	2018-10-04
NF-.kappa.B inhibitors and uses thereof Grant 8,552,206 - Tepe , et al. October 8, 2	2013-10-08
Multi-substituted imidazolines and method of use thereof Grant 7,858,808 - Tepe , et al. December 28, 2	2010-12-28
Multi-Substituted Imidazolines And Method Of Use Thereof App 20100204260 - Tepe; Jetze J. ; et al.	2010-08-12
Preparation of hymenialdisine derivatives and use thereof Grant 7,732,436 - Tepe June 8, 2	2010-06-08
Multi-substituted imidazolines and method of use thereof Grant 7,652,056 - Tepe , et al. January 26, 2	2010-01-26
NF- kB Inhibitors And Uses Thereof App 20090275603 - Tepe; Jetze J. ; et al.	2009-11-05
Preparation of hymenialdisine derivatives and use thereof Grant 7,601,710 - Tepe October 13, 2	2009-10-13
NF-kappaB inhibitors and uses thereof Grant 7,528,161 - Tepe May 5, 2	2009-05-05
Method for the enrichment and characterization of phosphorylated peptides or proteins Grant 7,423,132 - Tepe , et al. September 9, 2	2008-09-09
Preparation of hymenialdisine derivatives and use thereof Grant 7,385,055 - Tepe June 10, 2	2008-06-10
NF-kB inhibitors and uses thereof App 20080114015 - Tepe; Jetze J.	2008-05-15
NF-.kappa.B inhibitors and uses thereof Grant 7,345,078 - Tepe , et al. March 18, 2	2008-03-18
Preparation of hymenialdsine derivatives and use thereof Grant 7,335,769 - Tepe February 26, 2	2008-02-26
Preparation of hymenialdisine derivatives and use thereof Grant 7,193,079 - Tepe March 20, 2	2007-03-20
Preparation Of Hymenialdisine Derivatives And Use Thereof App 20070049575 - Tepe; Jetze J.	2007-03-01
Preparation of hymenialdisine derivatives and use thereof App 20060293305 - Tepe; Jetze J.	2006-12-28
Preparation of hymenialdsine derivatives and use thereof App 20060287296 - Tepe; Jetze J.	2006-12-21
Preparation of hymenialdisine derivatives and use thereof App 20060276451 - Tepe; Jetze J.	2006-12-07
Method for the enrichment and characterization of phosphorylated peptides or proteins App 20060014234 - Tepe; Jetze J. ; et al.	2006-01-19
Multi-substituted imidazolines and method of use thereof App 20050192330 - Tepe, Jetze J. ; et al.	2005-09-01
Multi-substituted imidazolines and method of use thereof Grant 6,878,735 - Tepe , et al. April 12, 2	2005-04-12
NF-kappaB inhibitors and uses thereof App 20050020586 - Tepe, Jetze J.	2005-01-27
Preparation of hymenialdisine derivatives and use thereof App 20040235820 - Tepe, Jetze J.	2004-11-25
NF-kB inhibitors and uses threreof App 20030232998 - Tepe, Jetze J.	2003-12-18
Multi-substituted imidazolines and method of use thereof App 20030232870 - Tepe, Jetze J. ; et al.	2003-12-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.